SK bioscience researchers were hurriedly conducting the final examination on the SKYCovione Covid-19 vaccine Wednesday afternoon at L House, the company’s manufacturing facility in Andong, North Gyeongsang, with the hope that it could be released as soon as the end of the month.

 
The examination is the final review before the company submits the lot release application to the Ministry of Food and Drug Safety. The company already won use approval in late June